India, July 10 -- People with diabetes require insulin injections as the pancreas' insulin production declines. To better manage blood sugar levels better, many patients need daily insulin injections throughout the week, every day. However, a revolutionary new injection has now entered the market that needs to be taken only once a week, fundamentally changing diabetes care.ALSO READ: Always exhausted? Endocrinologist explains why your constant fatigue is actually a warning sign

Novo Nordisk India has launched the world's first once-weekly basal insulin, Awiqli, for adults with type 1 and type 2 diabetes. It reduces the injection burden from seven injections a week to just one, bringing greater convenience to diabetes management. This way...